Dr. Devlina Chakravarty
#786Managing Director
57
Age
33y
Exp
19y
Tenure
5/10
Risk
🎓 MD · Mumbai University (MD trained); Fellowships: University of Berlin, UCLA, Brigham & Women's Boston
📜 DNB,DMRD,DHA · Mumbai University
🏛️ None
CompensationTBP
Personality
6
Open
7
Cons
5
Extr
6
Agre
3
Neur
Artemis Medicare
·
High Growth · Performance-Driven
About
Dr. Devlina Chakravarty is the Managing Director of Artemis Medicare, a company in the corporate sector with a market cap of ₹4K Cr. A Pragmatic leader with 33 years of experience, she is known for data-driven decision-making and organic builder strategy. She emphasizes medical quality standards and clinical excellence as the core pillars of business sustainability and patient trust.
FAQ
What is Dr. Devlina Chakravarty's leadership style?
Dr. Devlina Chakravarty is classified as a Pragmatic leader. She is data-driven in decision-making, with a shareholder champion motivation and steady-marathon pace of execution.
What is Dr. Devlina Chakravarty's educational background?
Dr. Devlina Chakravarty holds a MD from Mumbai University (MD trained); Fellowships: University of Berlin, UCLA, Brigham & Women's Boston and a DNB,DMRD,DHA from Mumbai University.
Who is the CEO of Artemis Medicare?
Dr. Devlina Chakravarty is the Managing Director of Artemis Medicare. She has been with the company for 19 years and in the current role for 0 years.
Leadership DNA
ArchetypePragmatic
MotivationShareholder Champion
CrisisSteady Hand
DecisionData-Driven
GrowthOrganic Builder
PeopleNumbers Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerPremium-Niche
EmployerLearning Ground
BrandTrusted
FocusOperational Excellence
OrientationDeep Specialist
Leadership Evidence
“She emphasizes medical quality standards and clinical excellence as the core pillars of business sustainability and patient trust.”
⚡ Crisis●●●●○
During the pandemic, Dr. Chakravarty focused on maintaining operational continuity and clinical safety standards at Artemis hospitals rather than aggressive cost-cutting or pivot-based restructuring.
🎯 Motivation●●●○○
As a professional MD in a publicly listed healthcare entity, her focus has consistently been on driving operational efficiency to improve the company's financial performance and investor value.
👥 People●●●●○
Dr. Chakravarty is widely recognized for her pragmatic, data-driven approach to hospital management, prioritizing clinical outcomes and operational metrics to drive performance.
📈 Growth●●●●○
Her tenure at Artemis has been defined by deepening the existing service portfolio and optimizing internal hospital operations rather than large-scale M&A or diversification.
💡 Innovation●●●●○
Artemis focuses on adopting global medical technologies and clinical protocols to scale its multi-specialty hospital chain rather than inventing new medical categories.
🏃 Pace●●●●○
The hospital sector requires long-term capital investment and consistent operational reliability rather than rapid-fire startup-style pivots.
🌱 Purpose●●●○○
The company emphasizes clinical excellence and patient care outcomes as a core pillar alongside its commercial hospital operations.
🏷️ Brand●●●●○
As a JCI-accredited institution, its brand equity is built on clinical safety, institutional credibility, and reliable patient outcomes.
🤝 Customer●●●●○
Artemis targets the urban, affluent demographic seeking high-end, specialized tertiary and quaternary healthcare services.
💼 Employer●●●○○
The institution is recognized as a hub for specialized medical training and clinical research, attracting healthcare professionals seeking to build expertise.
📋 Mandate
Needs aggressive footprint expansion and brand scaling to compete in the rapidly consolidating private healthcare sector.
🏢 Culture●●●○○
Healthcare service provider emphasizing operational efficiency and patient-outcome metrics under professional MD leadership.
Financials
Revenue FY25—
PAT FY25—
Rev CAGR 5Y—
OPM—
NPM—
ROE—
ROCE—
P/E98.4
Fwd P/E27.1
P/B4
D/E31.4
Promoter81%
Institutional1.8%
Mkt Cap₹4K Cr
Compensation
To Be Published
Data being verified from audited reports
